Anastrozole Market 2027 by Route of Administration, Distribution Channel and Geography | The Insight Partners

Anastrozole Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Route of Administration (Oral, Intravenous and Intramuscular); Distribution Channel (Hospital Pharmacies and Retail Pharmacies) and Geography

Report Code: TIPRE00008223 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Anastrozole is an aromatase inhibitor, which helps to decrease the overall levels of estrogen in a woman's body. The compound is prescribed for women who have had menopause. Anastrozole is preferred as a treatment for breast cancer among women. By the administration of this drug, estrogen is blocked, due to which the cancer cells feeding off estrogen may be unable able to survive.

MARKET DYNAMICS

The anastrozole market is anticipated to grow in the forecast, owing to the rising number of breast cancer cases. Also, the supportive government policies for cancer treatment are likely to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE

The "Anastrozole Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of anastrozole market with detailed market segmentation by route of administration, distribution channel and geography. The anastrozole market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading anastrozole market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The anastrozole market is segmented on the basis of route of administration and distribution channel. Based on mode of administration the market is segmented as, oral, intravenous and intramuscular. On the basis of distribution channel the market is categorized as, hospital pharmacies and retail pharmacies.



Get more information on this report :

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the anastrozole market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The anastrozole market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting anastrozole market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the anastrozole market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the anastrozole market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from anastrozole market are anticipated to have lucrative growth opportunities in the future with the rising demand for anastrozole market in the global market. Below mentioned is the list of few companies engaged in the anastrozole market.

The report also includes the profiles of key anastrozole market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Accord Healthcare Ireland Ltd
  •  Apotex Inc.
  •  Cipla Limited
  •  Hisun Pharmaceuticals USA Inc.
  •  JUVISÉ
  •  Mylan N.V.
  •  Natco Pharma (Canada) Inc.
  •  Synthon
  •  Teva Pharmaceuticals USA, Inc.
  •  Zydus Pharmaceuticals, Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Anastrozole Market - By Route of Administration
1.3.2 Anastrozole Market - By Distribution Channel
1.3.3 Anastrozole Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. ANASTROZOLE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. ANASTROZOLE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC

6. ANASTROZOLE MARKET - GLOBAL MARKET ANALYSIS
6.1. ANASTROZOLE - GLOBAL MARKET OVERVIEW
6.2. ANASTROZOLE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. ANASTROZOLE MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
7.1. OVERVIEW
7.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
7.3. ORAL
7.3.1. Overview
7.3.2. Oral Market Forecast and Analysis
7.4. INTRAVENOUS
7.4.1. Overview
7.4.2. Intravenous Market Forecast and Analysis
7.5. INTRAMUSCULAR
7.5.1. Overview
7.5.2. Intramuscular Market Forecast and Analysis

8. ANASTROZOLE MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis

9. ANASTROZOLE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Anastrozole Market Overview
9.1.2 North America Anastrozole Market Forecasts and Analysis
9.1.3 North America Anastrozole Market Forecasts and Analysis - By Route of Administration
9.1.4 North America Anastrozole Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Anastrozole Market Forecasts and Analysis - By Countries
9.1.5.1 United States Anastrozole Market
9.1.5.1.1 United States Anastrozole Market by Route of Administration
9.1.5.1.2 United States Anastrozole Market by Distribution Channel
9.1.5.2 Canada Anastrozole Market
9.1.5.2.1 Canada Anastrozole Market by Route of Administration
9.1.5.2.2 Canada Anastrozole Market by Distribution Channel
9.1.5.3 Mexico Anastrozole Market
9.1.5.3.1 Mexico Anastrozole Market by Route of Administration
9.1.5.3.2 Mexico Anastrozole Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Anastrozole Market Overview
9.2.2 Europe Anastrozole Market Forecasts and Analysis
9.2.3 Europe Anastrozole Market Forecasts and Analysis - By Route of Administration
9.2.4 Europe Anastrozole Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Anastrozole Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Anastrozole Market
9.2.5.1.1 Germany Anastrozole Market by Route of Administration
9.2.5.1.2 Germany Anastrozole Market by Distribution Channel
9.2.5.2 France Anastrozole Market
9.2.5.2.1 France Anastrozole Market by Route of Administration
9.2.5.2.2 France Anastrozole Market by Distribution Channel
9.2.5.3 Italy Anastrozole Market
9.2.5.3.1 Italy Anastrozole Market by Route of Administration
9.2.5.3.2 Italy Anastrozole Market by Distribution Channel
9.2.5.4 Spain Anastrozole Market
9.2.5.4.1 Spain Anastrozole Market by Route of Administration
9.2.5.4.2 Spain Anastrozole Market by Distribution Channel
9.2.5.5 United Kingdom Anastrozole Market
9.2.5.5.1 United Kingdom Anastrozole Market by Route of Administration
9.2.5.5.2 United Kingdom Anastrozole Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Anastrozole Market Overview
9.3.2 Asia-Pacific Anastrozole Market Forecasts and Analysis
9.3.3 Asia-Pacific Anastrozole Market Forecasts and Analysis - By Route of Administration
9.3.4 Asia-Pacific Anastrozole Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Anastrozole Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Anastrozole Market
9.3.5.1.1 Australia Anastrozole Market by Route of Administration
9.3.5.1.2 Australia Anastrozole Market by Distribution Channel
9.3.5.2 China Anastrozole Market
9.3.5.2.1 China Anastrozole Market by Route of Administration
9.3.5.2.2 China Anastrozole Market by Distribution Channel
9.3.5.3 India Anastrozole Market
9.3.5.3.1 India Anastrozole Market by Route of Administration
9.3.5.3.2 India Anastrozole Market by Distribution Channel
9.3.5.4 Japan Anastrozole Market
9.3.5.4.1 Japan Anastrozole Market by Route of Administration
9.3.5.4.2 Japan Anastrozole Market by Distribution Channel
9.3.5.5 South Korea Anastrozole Market
9.3.5.5.1 South Korea Anastrozole Market by Route of Administration
9.3.5.5.2 South Korea Anastrozole Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Anastrozole Market Overview
9.4.2 Middle East and Africa Anastrozole Market Forecasts and Analysis
9.4.3 Middle East and Africa Anastrozole Market Forecasts and Analysis - By Route of Administration
9.4.4 Middle East and Africa Anastrozole Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Anastrozole Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Anastrozole Market
9.4.5.1.1 South Africa Anastrozole Market by Route of Administration
9.4.5.1.2 South Africa Anastrozole Market by Distribution Channel
9.4.5.2 Saudi Arabia Anastrozole Market
9.4.5.2.1 Saudi Arabia Anastrozole Market by Route of Administration
9.4.5.2.2 Saudi Arabia Anastrozole Market by Distribution Channel
9.4.5.3 U.A.E Anastrozole Market
9.4.5.3.1 U.A.E Anastrozole Market by Route of Administration
9.4.5.3.2 U.A.E Anastrozole Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Anastrozole Market Overview
9.5.2 South and Central America Anastrozole Market Forecasts and Analysis
9.5.3 South and Central America Anastrozole Market Forecasts and Analysis - By Route of Administration
9.5.4 South and Central America Anastrozole Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Anastrozole Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Anastrozole Market
9.5.5.1.1 Brazil Anastrozole Market by Route of Administration
9.5.5.1.2 Brazil Anastrozole Market by Distribution Channel
9.5.5.2 Argentina Anastrozole Market
9.5.5.2.1 Argentina Anastrozole Market by Route of Administration
9.5.5.2.2 Argentina Anastrozole Market by Distribution Channel

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. ANASTROZOLE MARKET, KEY COMPANY PROFILES
11.1. ACCORD HEALTHCARE IRELAND LTD
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. APOTEX INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. CIPLA LIMITED
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. HISUN PHARMACEUTICALS USA INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. JUVISÉ
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. MYLAN N.V.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. NATCO PHARMA (CANADA) INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. SYNTHON
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. TEVA PHARMACEUTICALS USA, INC.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. ZYDUS PHARMACEUTICALS, INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Accord Healthcare Ireland Ltd
2. Apotex Inc.
3. Cipla Limited
4. Hisun Pharmaceuticals USA Inc.
5. JUVISÉ
6. Mylan N.V.
7. Natco Pharma (Canada) Inc.
8. Synthon
9. Teva Pharmaceuticals USA, Inc.
10. Zydus Pharmaceuticals, Inc.
TIPRE00008223
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking